Related references
Note: Only part of the references are listed.Brazilian Guidelines of Hypertension-2020
Weimar Kunz Sebba Barroso et al.
ARQUIVOS BRASILEIROS DE CARDIOLOGIA (2021)
Nebivolol in the treatment of arterial hypertension
Nasima Olawi et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2019)
Three Generations of β-blockers: History, Class Differences and Clinical Applicability
Gabriel T. do Vale et al.
CURRENT HYPERTENSION REVIEWS (2019)
Landiolol for managing post-operative atrial fibrillation
Martin Balik et al.
EUROPEAN HEART JOURNAL SUPPLEMENTS (2018)
A Critical Review of Nebivolol and its Fixed-Dose Combinations in the Treatment of Hypertension
Arrigo F. G. Cicero et al.
DRUGS (2018)
Evaluation of amiodarone versus metoprolol in treating atrial fibrillation after coronary artery bypass grafting
Alireza Kamali et al.
INTERVENTIONAL MEDICINE AND APPLIED SCIENCE (2017)
Early Cardioversion in Atrial Fibrillation: Earlier Is Better, but Not Always and (Maybe) Not Immediately
Paloma G. Pina et al.
CURRENT ATHEROSCLEROSIS REPORTS (2017)
β-adrenergic receptor signalling and its functional consequences in the diseased heart
Aref Najafi et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2016)
Non-invasive assessment of the effect of beta blockers and calcium channel blockers on the AV node during permanent atrial fibrillation
Frida Sandberg et al.
JOURNAL OF ELECTROCARDIOLOGY (2015)
Nebivolol: Vasodilator Properties and Evidence for Relevance in Treatment of Cardiovascular Disease
Jonathan G. Howlett
CANADIAN JOURNAL OF CARDIOLOGY (2014)
Cryptogenic Stroke and Underlying Atrial Fibrillation
Tommaso Sanna et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Nebivolol in preventing atrial fibrillation following coronary surgery in patients over 60 years of age
Nevzat Erdil et al.
REVISTA BRASILEIRA DE CIRURGIA CARDIOVASCULAR (2014)
β1-blockers lower norepinephrine release by inhibiting presynaptic, facilitating β1-adrenoceptors in normotensive and hypertensive rats
Torill Berg
FRONTIERS IN NEUROLOGY (2014)
Oral carvedilol in escalating doses in the acute treatment of atrial fibrillation
Ravi Venkatachelam Chitrapu et al.
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2014)
Beta blockers, nitric oxide, and cardiovascular disease
Paul M. Vanhoutte et al.
CURRENT OPINION IN PHARMACOLOGY (2013)
Effect of landiolol hydrochloride, an ultra-short-acting beta 1-selective blocker, on supraventricular tachycardia, atrial fibrillation and flutter after pulmonary resection
T. Nakano et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2012)
β-Adrenergic Regulation of the Cardiac Na+-K+ ATPase Mediated by Oxidative Signaling
Keyvan Karimi Galougahi et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2012)
Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: New evidence from the PASCAL trial
Akira Sezai et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2011)
THE EFFECT OF PROPRANOLOL ON PLASMA RENIN ACTIVITY AND BLOOD PRESSURE IN MILD ESSENTIAL HYPERTENSION
Lennart Hansson et al.
ACTA MEDICA SCANDINAVICA (2010)
Ambulatory Arrhythmia Monitoring Choosing the Right Device
Peter Zimetbaum et al.
CIRCULATION (2010)
Current Perceptions of the Epidemiology of Atrial Fibrillation
William B. Kannel et al.
CARDIOLOGY CLINICS (2009)
Ability of Amiodarone and Propranolol Alone or in Combination to Prevent Post-coronary Bypass Atrial Fibrillation
Javad Kojuri et al.
CARDIOVASCULAR THERAPEUTICS (2009)
Stereoselective Analysis of Labetalol in Human Plasma by LC-MS/MS: Application to Pharmacokinetics
Teresa Maria De Jesus Ponte Carvalho et al.
CHIRALITY (2009)
Rabbit, a relevant model for the study of cardiac β3-adrenoceptors
Leslie Audigane et al.
EXPERIMENTAL PHYSIOLOGY (2009)
Optimal β-blocker for prevention of atrial fibrillation after on-pump coronary artery bypass graft surgery:: Carvedilol versus metoprolol
Majid Haghjoo et al.
HEART RHYTHM (2007)
The vasoldilatory beta-blockers
Michala E. Pedersen et al.
CURRENT HYPERTENSION REPORTS (2007)
Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: The Fibrillation Registry Assessing Costs, Therapies, Adverse events and Lifestyle (FRACTAL) study
Matthew R. Reynolds et al.
AMERICAN HEART JOURNAL (2006)
Molecular physiology of cardiac repolarization
JM Nerbonne et al.
PHYSIOLOGICAL REVIEWS (2005)
Studying cardiac arrhythmias in the mouse - A reasonable model for probing mechanisms?
JM Nerbonne
TRENDS IN CARDIOVASCULAR MEDICINE (2004)
Basic mechanisms of cardiac impulse propagation and associated arrhythmias
AG Kléber et al.
PHYSIOLOGICAL REVIEWS (2004)
Cardiovascular drug class specificity:: β-blockers
MJ Reiter
PROGRESS IN CARDIOVASCULAR DISEASES (2004)
Pharmacology of carvedilol
B Dulin et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Role of carvedilol in atrial fibrillation: Insights from clinical trials
M Gheorghiade et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Molecular genetics of arrhythmias and cardiovascular conditions associated with arrhythmias
C Antzelevitch
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2003)
Plasma membrane channels formed by connexins:: Their regulation and functions
JC Sáez et al.
PHYSIOLOGICAL REVIEWS (2003)
Sources and significance of plasma levels of catechols and their metabolites in humans
DS Goldstein et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Heterogeneous expression of voltage-gated potassium channels in the heart: Roles in normal excitation and arrhythmias
JM Nerbonne et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2002)
The role of myocardial gap junctions in electrical conduction and arrhythmogenesis
S Kanno et al.
CARDIOVASCULAR PATHOLOGY (2001)
Share Paper
